Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA

Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01253070	Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia	completed	Phase 2	54	National Cancer Institute (NCI)NIH	1	Aug 4, 2022	clinicaltrials
NCT01445080	Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia	completed	Phase 1 / Phase 2	70	National Cancer Institute (NCI)NIH	2	Feb 2, 2021	clinicaltrials